천식 관리용 웨어러블 시장 : 전략적 인사이트와 예측(2026-2031년)

The Wearables for Asthma Management Market, sustaining an 8.16% CAGR, is forecasted to rise from USD 991.559 million in 2025 to USD 1587.315 million in 2031.

The wearables for asthma management market is undergoing significant transformation driven by the paradigm shift toward remote patient monitoring, the growing emphasis on medication adherence, and the increasing integration of digital health tools into chronic respiratory care. The market's evolution is characterized by the recognition that wearable technologies can address persistent challenges in asthma management, including medication non-adherence, symptom monitoring, trigger identification, and long-term disease control. The convergence of smart inhalers, connected sensors, mobile applications, and analytics platforms is enabling more objective, continuous, and actionable respiratory health data. Healthcare providers are increasingly using adherence data to identify high-risk patients and intervene before disease control deteriorates, while patients benefit from real-time feedback, reminders, and personalized insights. The market is witnessing significant investment in connected inhaler technologies, integrated respiratory management platforms, and evidence generation, positioning wearables as a critical complement to pharmaceutical therapy in asthma management.

Market Drivers

• Persistent medication non-adherence in asthma care represents the primary driver for the wearables for asthma management market. Medication adherence remains one of the most widely documented challenges in respiratory disease management. Patients frequently miss maintenance doses, use inhalers incorrectly, or discontinue therapy when symptoms improve. Smart inhalers equipped with sensors, reminders, and usage tracking capabilities directly address these challenges. Healthcare providers increasingly use adherence data to identify high-risk patients and intervene before disease control deteriorates, resulting in sustained growth in wearable asthma management utilization. The expansion of remote patient monitoring programs is further accelerating market growth through increased demand for connected respiratory monitoring. Healthcare providers continue to invest in remote care infrastructure as chronic disease management shifts beyond traditional clinical settings. Connected respiratory monitoring devices allow clinicians to track symptoms, inhaler use, lung function trends, and environmental exposures between appointments. This capability aligns with broader healthcare objectives focused on reducing avoidable hospital admissions and emergency care utilization. The growing emphasis on value-based healthcare delivery is strengthening the business case for wearable asthma technologies. Payers and healthcare systems are increasingly evaluating treatment approaches based on measurable patient outcomes rather than service volume alone. Continuous monitoring tools can provide objective evidence regarding medication use, symptom progression, and treatment effectiveness. This creates a stronger business case for wearable asthma technologies when they demonstrate reductions in acute care utilization or improvements in disease control metrics. Advances in sensor miniaturization and mobile connectivity are improving the usability of wearable respiratory devices. Improvements in sensor performance, battery efficiency, wireless connectivity, and mobile application ecosystems have improved the usability of wearable respiratory devices.

Market Restraints

• Fragmented reimbursement frameworks create barriers to broader adoption. Coverage policies for remote monitoring devices, digital therapeutics, and connected respiratory platforms vary significantly across countries and healthcare systems. Clinical workflow integration challenges can create an additional administrative burden for clinicians. Healthcare providers increasingly require wearable-generated data to integrate directly into existing clinical systems. Patient engagement sustainability remains difficult across many digital health categories. Initial device adoption does not always translate into sustained use over multiple years. Data privacy and cybersecurity requirements increase development costs and regulatory complexity. Clinical validation requirements can be particularly challenging for smaller digital health companies.

Technology and Product Insights

• The technology landscape is characterized by the growing importance of smart inhalers, connected sensors, and integrated respiratory management platforms. Smart inhalers represent the most commercially important segment because they directly address one of asthma management's most persistent challenges: medication adherence. Unlike broader wellness-oriented wearables, smart inhalers are closely linked to therapeutic intervention and generate data directly associated with treatment compliance. Healthcare providers increasingly value smart inhalers because they produce objective usage records rather than relying on patient self-reporting. These devices can record inhaler actuation events, provide dose reminders, identify usage patterns, and transmit data to clinicians or caregivers. Such capabilities support earlier intervention when adherence declines or rescue inhaler use increases. The segment analysis reveals that competition increasingly centers on ecosystem development rather than sensor technology alone. Companies that combine inhaler connectivity with symptom tracking, environmental monitoring, predictive analytics, and telehealth integration are likely to strengthen their competitive position relative to suppliers offering standalone monitoring functionality. North America represents the largest commercial opportunity due to extensive digital health investment, high healthcare expenditure, established remote monitoring infrastructure, and widespread smartphone adoption. European respiratory disease management remains a priority across several healthcare systems, with countries including Germany, the United Kingdom, and France continuing to expand digital healthcare capabilities. Asia Pacific countries with large patient populations, increasing healthcare digitization, and expanding smartphone penetration are expected to account for substantial regional demand. The integration of analytics platforms is becoming increasingly important as providers and healthcare systems evaluate integration with electronic health records, compatibility with existing inhaler platforms, patient usability, battery life, and data analytics capabilities.

Competitive and Strategic Outlook

• The competitive landscape exhibits characteristics of a technology-driven and healthcare-integration-focused environment where device functionality remains important, but competitive differentiation increasingly depends on software capabilities, analytics, interoperability, clinical evidence, and healthcare ecosystem integration. Propeller Health, now operating within ResMed's broader digital health portfolio, has established a strong position through connected inhaler technologies and respiratory monitoring platforms, with integration within a larger respiratory care ecosystem providing advantages in data analytics, patient engagement, and healthcare provider connectivity. Adherium Limited continues to focus on medication adherence monitoring solutions. Teva Pharmaceuticals has pursued connected inhaler initiatives linked to pharmaceutical therapy management. AstraZeneca's involvement reflects growing pharmaceutical interest in combining therapeutics with digital disease management tools. NuvoAir, Cohero Health, Amiko Digital Health, Health Care Originals, Inspirx, and Healthimation are pursuing various combinations of remote monitoring, digital therapeutics, respiratory analytics, and patient engagement technologies. Competition increasingly centers on demonstrating clinical outcomes, securing healthcare partnerships, and integrating respiratory monitoring into broader chronic disease management workflows. Barriers to entry are increasing as healthcare providers demand stronger clinical validation, cybersecurity compliance, regulatory approval capabilities, and interoperability standards. Recent key developments include Masimo securing FDA clearance for Radius VSM, a body-worn continuous monitoring device that enables remote tracking of physiological parameters with respiratory monitoring applications. Cipla introduced Ciposcillo, an advanced oscillometer for early assessment of asthma and other obstructive airway diseases. Signant Health acquired Ametris, adding wearable-derived digital outcome measurement capabilities applicable to asthma studies and decentralized clinical trials. Aptar Digital Health obtained FDA clearance for HeroTracker Sense, a Bluetooth-enabled inhaler attachment that converts conventional inhalers into connected devices.

Short Conclusion

• The wearables for asthma management market is positioned for sustained growth driven by the convergence of medication adherence challenges, remote monitoring expansion, and technological innovation. The transition from standalone devices toward integrated respiratory management platforms represents a fundamental shift in chronic disease management. While challenges related to reimbursement fragmentation, workflow integration, and patient engagement persist, strategic investments in ecosystem development, clinical evidence, and healthcare partnerships are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with wearables evolving into a critical complement to pharmaceutical therapy, supporting adherence, symptom monitoring, and improved outcomes across global healthcare systems.

Key Benefits of this Report

• Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

• Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation, and trade analysis
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TYPE

• 5.1. Introduction
• 5.2. Smart Inhalers
• 5.3. Wearable Spirometers
• 5.4. Activity Trackers with Asthma Monitoring

6. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Bluetooth Connectivity
• 6.3. Sensor Technology
• 6.4. Mobile Apps and Platforms

7. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Asthma Symptom Monitoring
• 7.3. Medication Adherence Tracking
• 7.4. Peak Flow Rate Monitoring
• 7.5. Trigger Identification
• 7.6. Personalized Asthma Management

8. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY END-USER

• 8.1. Introduction
• 8.2. Patients With Asthma
• 8.3. Healthcare Providers
• 8.4. Hospitals And Clinics
• 8.5. Research Institutions

9. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Propeller Health (Now Part of ResMed)
• 11.2. Adherium Limited
• 11.3. Teva Pharmaceuticals
• 11.4. Cohero Health
• 11.5. Nuvoair
• 11.6. Astrazeneca Plc
• 11.7. Health Care Originals
• 11.8. Inspirx, Inc.
• 11.9. Amiko Digital Health Limited
• 11.10. Healthimation, LLC

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations